Precision BioSciences presents preclinical data for gene editing therapies May 17, 2022 -- Precision BioSciences is scheduled to display preclinical data for its Arcus-based gene editing studies at the American Society of Gene & Cell Therapy’s annual meeting in Washington, DC. The showcase will include two oral presentations and two posters highlighting gene editing study results.Read More
Avantor and Cytovance enter into plasmid manufacturing agreement May 11, 2022 -- Avantor and Cytovance Biologics have entered into an agreement to advance the manufacturing of plasmids. This agreement will combine Avantor’s expertise in providing cell and gene therapy materials with Cytovance’s plasmid DNA manufacturing capabilities.Read More
RedShift BioAnalytics releases biomolecule characterization technology May 4, 2022 -- RedShift BioAnalytics has launched its novel Apollo technology for advanced microfluidic modulation spectroscopy. This technology enables highly sensitive and precise measurement of biomolecules with improved efficiency and decreased sample volume compared to the company's previous AQS3 pro structural analysis technology.Read More
Bruker debuts compact 1.0 GHz NMR magnet April 27, 2022 -- Bruker debuted a compact 1.0 GHz nuclear magnetic resonance (NMR) magnet for use in structural biology laboratories at the Experimental Nuclear Magnetic Resonance Conference 2022.Read More
Bruker showcases new assays at ECCMIB 2022 April 25, 2022 -- Bruker debuted new multiplex polymerase chain reaction (PCR) infectious disease assays and upgrades to its existing matrix-assisted laser desorption/ionization (MALDI) Biotyper platform at the annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMIB).Read More
Purigen enters into distribution agreement with GC biotech April 21, 2022 -- Purigen Biosystems has entered into a distribution agreement with GC biotech in support of its automated Ionic Purification System. The agreement gives GC biotech rights in Europe to distribute, service, and support the purification system, in addition to microfluidics kits.Read More
Biovectra breaks ground on mRNA vaccine and biomanufacturing center April 19, 2022 -- Biovectra has started construction of an mRNA vaccine and biomanufacturing center in Charlottetown, Prince Edward Island. With government support, the facility will strengthen Biovectra’s capabilities in the manufacturing of mRNA vaccines and therapeutics when it begins operation in 2023.Read More
Agilent demonstrates cell analysis solutions for cancer at AACR 2022 April 12, 2022 -- Agilent Technologies will display its cancer research tools for the enhanced study of cell functionality, characteristics, and other properties at the American Association for Cancer Research (AACR) 2022 Annual Meeting held in New Orleans.Read More
Oxford BioTherapeutics to present clinical data at AACR April 11, 2022 -- Oxford BioTherapeutics will present preliminary clinical data from its ongoing expansion phase I trial of its experimental CD205-directed antibody drug conjugate, OBT076, on April 11 at the American Association of Cancer Research (AACR) Annual Meeting.Read More